-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Xeris Biopharma Holdings, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2021 to Q1 2024.
- Xeris Biopharma Holdings, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $326K, a 10.4% decline year-over-year.
- Xeris Biopharma Holdings, Inc. annual Depreciation, Depletion and Amortization for 2023 was $1.49M, a 6.29% increase from 2022.
- Xeris Biopharma Holdings, Inc. annual Depreciation, Depletion and Amortization for 2022 was $1.4M, a 5.27% increase from 2021.
- Xeris Biopharma Holdings, Inc. annual Depreciation, Depletion and Amortization for 2021 was $1.33M, a 9.41% decline from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)